Gene · 6921
NIH grants1,232
NIH grants whose papers are about the gene, through NIH's grant-paper links.
281 to 300 of 1,232
Download this page as JSON| Grant | Title | ELOC papers | Newest fiscal year |
|---|---|---|---|
| U01CA243004 | Multiscale analysis of metabolic inflammation as a driver of breast cancer | 1 | 2024 |
| U01CA247439 | Deciphering Clonal Evolution in Hereditary Renal Cell Carcinomas | 1 | 2024 |
| U01HL098147 | Genomic Effects on Right Ventricular Function, Clinical Features and Outcomes in CHD | 1 | 2024 |
| ZIABC009392 | Determining the Fate of Transmembrane Proteins | 1 | 2024 |
| ZIABC010683 | Role of fumarate hydratase loss in development of HLRCC hereditary kidney cancer | 1 | 2024 |
| ZIADK033007 | Biophysics of Macromolecular Complexes | 1 | 2024 |
| ZIAHD008735 | Diagnosis, Pathophysiology And Molecular Biology of Pheochromocytoma and Paraganglioma | 1 | 2024 |
| R01CA177910 | Novel regulation of PI3K/Akt to direct targeted breast cancer therapies | 3 | 2023 |
| R01CA242003 | Use of BCL-xL Proteolysis targeting chimeras to treat pancreatic cancer | 3 | 2023 |
| P41GM109824 | National Center for Dynamic Interactome Research | 2 | 2023 |
| R01AI143292 | Novel VP30-host Interactions that Negatively Regulate Ebola Virus Infection | 2 | 2023 |
| R01CA247365 | Chemical Biology of the Control of Neddylation by DCN1 | 2 | 2023 |
| R01GM032136 | Molecular Recognition of Proteins and Ligand Design | 2 | 2023 |
| R01GM114141 | Mechanisms mediating immune response upon sensing of nuclear viral DNA | 2 | 2023 |
| U01CA272612 | Translating novel cancer targets and mechanisms from the CTD^2 Network using molecular glues | 2 | 2023 |
| F32AG076281 | Molecular recognition of pathological tau fibril conformations | 1 | 2023 |
| K99AG073461 | Defining the landscape and mechanisms of redox regulation of metabolism during aging | 1 | 2023 |
| K99AG078342 | Modulating Alzheimer’s Disease by mTORC1 inhibition to augment lysosomal activity | 1 | 2023 |
| P01AG003991 | Healthy Aging and Senile Dementia | 1 | 2023 |
| P01DK096990 | New Therapies for Liver Fibrosis and Hyperproliferation in Alpha1-AT Deficiency | 1 | 2023 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6921/grants?page=15